Immune evasion on the nanoscale: Small extracellular vesicles in pancreatic ductal adenocarcinoma immunity

Semin Cancer Biol. 2023 Nov:96:36-47. doi: 10.1016/j.semcancer.2023.09.004. Epub 2023 Sep 23.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer alarmingly expanding in our modern societies that is still proving to be very challenging to counteract. This disease constitutes a quintessential example of the multiple interactions existing between the tumour and its surrounding microenvironment. In particular, PDAC is characterized by a very immunosuppressive environment that favours cancer growth and makes this cancer type very resistant to immunotherapy. The primary tumour releases many factors that influence both the microenvironment and the immune landscape. Extracellular vesicles (EVs), recently identified as indispensable entities ensuring cell-to-cell communication in both physiological and pathological processes, seem to play a pivotal function in ensuring the delivery of these factors to the tumour-surrounding tissues. In this review, we summarize the present understanding on the crosstalk among tumour cells and the cellular immune microenvironment emphasizing the pro-malignant role played by extracellular vesicles. We also discuss how a greater knowledge of the roles of EVs in tumour immune escape could be translated into clinical applications.

Keywords: Biomarker; Cell signalling; Extracellular vesicle; Immune; Pancreatic cancer.

Publication types

  • Review

MeSH terms

  • Carcinoma, Pancreatic Ductal* / pathology
  • Extracellular Vesicles* / pathology
  • Humans
  • Immune Evasion
  • Pancreatic Neoplasms* / pathology
  • Tumor Microenvironment